237 related articles for article (PubMed ID: 8428580)
1. The NF-kappa B precursor p105 and the proto-oncogene product Bcl-3 are I kappa B molecules and control nuclear translocation of NF-kappa B.
Naumann M; Wulczyn FG; Scheidereit C
EMBO J; 1993 Jan; 12(1):213-22. PubMed ID: 8428580
[TBL] [Abstract][Full Text] [Related]
2. The bcl-3 proto-oncogene encodes a nuclear I kappa B-like molecule that preferentially interacts with NF-kappa B p50 and p52 in a phosphorylation-dependent manner.
Nolan GP; Fujita T; Bhatia K; Huppi C; Liou HC; Scott ML; Baltimore D
Mol Cell Biol; 1993 Jun; 13(6):3557-66. PubMed ID: 8497270
[TBL] [Abstract][Full Text] [Related]
3. The ankyrin repeat domains of the NF-kappa B precursor p105 and the protooncogene bcl-3 act as specific inhibitors of NF-kappa B DNA binding.
Hatada EN; Nieters A; Wulczyn FG; Naumann M; Meyer R; Nucifora G; McKeithan TW; Scheidereit C
Proc Natl Acad Sci U S A; 1992 Mar; 89(6):2489-93. PubMed ID: 1532257
[TBL] [Abstract][Full Text] [Related]
4. The precursor of NF-kappa B p50 has I kappa B-like functions.
Rice NR; MacKichan ML; Israël A
Cell; 1992 Oct; 71(2):243-53. PubMed ID: 1423592
[TBL] [Abstract][Full Text] [Related]
5. Interaction of the C-terminal region of p105 with the nuclear localisation signal of p50 is required for inhibition of NF-kappa B DNA binding activity.
Matthews JR; Watson E; Buckley S; Hay RT
Nucleic Acids Res; 1993 Sep; 21(19):4516-23. PubMed ID: 7694229
[TBL] [Abstract][Full Text] [Related]
6. The activity of a 70 kilodalton I kappa B molecule identical to the carboxyl terminus of the p105 NF-kappa B precursor is modulated by protein kinase A.
Gerondakis S; Morrice N; Richardson IB; Wettenhall R; Fecondo J; Grumont RJ
Cell Growth Differ; 1993 Aug; 4(8):617-27. PubMed ID: 8398903
[TBL] [Abstract][Full Text] [Related]
7. Candidate proto-oncogene bcl-3 encodes a subunit-specific inhibitor of transcription factor NF-kappa B.
Wulczyn FG; Naumann M; Scheidereit C
Nature; 1992 Aug; 358(6387):597-9. PubMed ID: 1501714
[TBL] [Abstract][Full Text] [Related]
8. I kappa B/MAD-3 masks the nuclear localization signal of NF-kappa B p65 and requires the transactivation domain to inhibit NF-kappa B p65 DNA binding.
Ganchi PA; Sun SC; Greene WC; Ballard DW
Mol Biol Cell; 1992 Dec; 3(12):1339-52. PubMed ID: 1493333
[TBL] [Abstract][Full Text] [Related]
9. p105 and p98 precursor proteins play an active role in NF-kappa B-mediated signal transduction.
Mercurio F; DiDonato JA; Rosette C; Karin M
Genes Dev; 1993 Apr; 7(4):705-18. PubMed ID: 8458581
[TBL] [Abstract][Full Text] [Related]
10. Promoter of the human NF-kappa B p50/p105 gene. Regulation by NF-kappa B subunits and by c-REL.
Cogswell PC; Scheinman RI; Baldwin AS
J Immunol; 1993 Apr; 150(7):2794-804. PubMed ID: 8454856
[TBL] [Abstract][Full Text] [Related]
11. HTLV-I encoded Tax in association with NF-kappa B precursor p105 enhances nuclear localization of NF-kappa B p50 and p65 in transfected cells.
Watanabe M; Muramatsu M; Hirai H; Suzuki T; Fujisawa J; Yoshida M; Arai K; Arai N
Oncogene; 1993 Nov; 8(11):2949-58. PubMed ID: 8414497
[TBL] [Abstract][Full Text] [Related]
12. BCL3 encodes a nuclear protein which can alter the subcellular location of NF-kappa B proteins.
Zhang Q; Didonato JA; Karin M; McKeithan TW
Mol Cell Biol; 1994 Jun; 14(6):3915-26. PubMed ID: 8196632
[TBL] [Abstract][Full Text] [Related]
13. Common structural constituents confer I kappa B activity to NF-kappa B p105 and I kappa B/MAD-3.
Hatada EN; Naumann M; Scheidereit C
EMBO J; 1993 Jul; 12(7):2781-8. PubMed ID: 8334994
[TBL] [Abstract][Full Text] [Related]
14. The NF-kappa B p50 precursor, p105, contains an internal I kappa B-like inhibitor that preferentially inhibits p50.
Liou HC; Nolan GP; Ghosh S; Fujita T; Baltimore D
EMBO J; 1992 Aug; 11(8):3003-9. PubMed ID: 1639070
[TBL] [Abstract][Full Text] [Related]
15. Lipopolysaccharide induces phosphorylation of MAD3 and activation of c-Rel and related NF-kappa B proteins in human monocytic THP-1 cells.
Cordle SR; Donald R; Read MA; Hawiger J
J Biol Chem; 1993 Jun; 268(16):11803-10. PubMed ID: 8505309
[TBL] [Abstract][Full Text] [Related]
16. NF-kappaB p105 is a target of IkappaB kinases and controls signal induction of Bcl-3-p50 complexes.
Heissmeyer V; Krappmann D; Wulczyn FG; Scheidereit C
EMBO J; 1999 Sep; 18(17):4766-78. PubMed ID: 10469655
[TBL] [Abstract][Full Text] [Related]
17. I kappa B interacts with the nuclear localization sequences of the subunits of NF-kappa B: a mechanism for cytoplasmic retention.
Beg AA; Ruben SM; Scheinman RI; Haskill S; Rosen CA; Baldwin AS
Genes Dev; 1992 Oct; 6(10):1899-913. PubMed ID: 1340770
[TBL] [Abstract][Full Text] [Related]
18. NF-kappa B precursor p100 inhibits nuclear translocation and DNA binding of NF-kappa B/rel-factors.
Naumann M; Nieters A; Hatada EN; Scheidereit C
Oncogene; 1993 Aug; 8(8):2275-81. PubMed ID: 8336950
[TBL] [Abstract][Full Text] [Related]
19. Characterization of ES cells deficient for the p105 precursor (NF-kappa B1): role of p50 NLS.
Ishikawa H; Ryseck RP; Bravo R
Oncogene; 1996 Jul; 13(2):255-63. PubMed ID: 8710364
[TBL] [Abstract][Full Text] [Related]
20. The subunit composition of NF-kappa B complexes changes during B-cell development.
Grumont RJ; Gerondakis S
Cell Growth Differ; 1994 Dec; 5(12):1321-31. PubMed ID: 7696180
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
